Affiris, Biolution GmbH, Forschungszentrum Juelich GmbH, French Clinical Research Infrastructure Network (F-Crin), Medical University Innsbruck, Prosenex Ambula

The SYMPATH consortium received €6 million ($8.3 million) under the EU's Seventh Framework Programme (FP7). The consortium, which will run for 48 months, is developing two vaccine candidates from Affiris against Parkinson's disease and multiple system atrophy (MSA). The candidates - PD01A and PD03A - both target alpha synuclein (SNCA) and will begin Phase I testing for both PD and MSA this summer. ...